Beneficient (BENF) Cash & Equivalents (2022 - 2025)

Beneficient's Cash & Equivalents history runs 4 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• In Q4 2025, Cash & Equivalents rose 89.61% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $7.9 million (up 89.61% YoY), while the FY2025 annual figure was $1.3 million, down 82.99% from the prior year.
• Cash & Equivalents came in at $7.9 million for Q4 2025 at Beneficient, up from $4.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $70.6 million in Q1 2022 to a low of $1.3 million in Q1 2025.
• A 4-year average of $10.7 million and a median of $4.9 million in 2025 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents plunged 87.64% in 2023 and surged 89.61% in 2025, its largest moves.
• Beneficient's Cash & Equivalents stood at $70.6 million in 2022, then sank by 84.13% to $11.2 million in 2023, then slumped by 62.96% to $4.1 million in 2024, then soared by 89.61% to $7.9 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $7.9 million, $4.9 million, and $7.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison